Phacoemulcification with Intravitreal Bevacizumab Injection in Patients with Cataract and Coexisting Diabetic Retinopathy: Prospective Randomized Study
Journal of Ocular Pharmacology and Therapeutics, 05/24/2012
Clinical Article
Salehi A et al. – Intravitreal administration of 1.25 mg bevacizumab at the time of cataract surgery was safe and effective in preventing the progression of diabetic retinopathy (DR) and diabetic maculopathy in patients with cataract and DR.



